Analysis of HIV latent infection model with multiple infection stages and different drug classes
Department
Medicine
Document Type
Article
Publication Title
Journal of Biological Dynamics
Abstract
Latently infected CD 4 + T cells represent one of the major obstacles to HIV eradication even after receiving prolonged highly active anti-retroviral therapy (HAART). Long-term use of HAART causes the emergence of drug-resistant virus which is then involved in HIV transmission. In this paper, we develop mathematical HIV models with staged disease progression by incorporating entry inhibitor and latently infected cells. We find that entry inhibitor has the same effect as protease inhibitor on the model dynamics and therefore would benefit HIV patients who developed resistance to many of current anti-HIV medications. Numerical simulations illustrate the theoretical results and show that the virus and latently infected cells reach an infected steady state in the absence of treatment and are eliminated under treatment whereas the model including homeostatic proliferation of latently infected cells maintains the virus at low level during suppressive treatment. Therefore, complete cure of HIV needs complete eradication of latent reservoirs.
First Page
713
Last Page
732
DOI
10.1080/17513758.2022.2113828
Volume
16
Issue
1
Publication Date
12-1-2022
Medical Subject Headings
Humans; HIV Infections; Virus Latency; HIV-1; CD4-Positive T-Lymphocytes; Models, Biological; Latent Infection; Protease Inhibitors
PubMed ID
36264087
Recommended Citation
Alshorman, A., Al-Hosainat, N., & Jackson, T. (2022). Analysis of HIV latent infection model with multiple infection stages and different drug classes. Journal of Biological Dynamics, 16 (1), 713-732. https://doi.org/10.1080/17513758.2022.2113828